Evaluation of bioequivalence and safety analysis of capecitabine tablets and Xeloda® under postprandial dosing conditions in Chinese patients with solid tumor.
Li H, Shan R, Ding J, Zhang J, Liu B, Ge Q, Cheng D, Li L, Zhang C, Su H, Li X, Li H, Ye J, Li H, Li F, Zhou H, Huo Q, Su Y.
Li H, et al.
Expert Opin Drug Metab Toxicol. 2023 Dec;19(12):1015-1021. doi: 10.1080/17425255.2023.2292735. Epub 2024 Jan 12.
Expert Opin Drug Metab Toxicol. 2023.
PMID: 38059472
Clinical Trial.